Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pimpinelli

Showing results (481-490 of 542) with videos related to

Pageof 55
Sort By:
Italian Journal of Dermatology and Venereology|July 5, 2022
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologicsFrancesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|June 19, 2014
Follow-up of cutaneous melanoma patients: a proposal for standardizationE Moscarella, C Ricci, L Borgognoni, et al.
Cells|February 15, 2022
Characterization of <i>Gfat1</i> (<i>zeppelin</i>) and <i>Gfat2</i>, Essential Paralogous Genes Which Encode the Enzymes That Catalyze the Rate-Limiting Step in the Hexosamine Biosynthetic Pathway in <i>Drosophila melanogaster</i>Shawn Cotsworth, Catherine J Jackson, Graham Hallson, et al.
Dermatology Practical & Conceptual|December 4, 2023
Burden of Disease in the Real-Life Setting of Patients with Atopic Dermatitis: Italian Data From the MEASURE-AD StudyGiuseppe Argenziano, Santo Raffaele Mercuri, Paola Savoia, et al.
Frontiers in Cellular and Infection Microbiology|December 28, 2020
Biofilm Production by Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Significantly Increases the Risk of Death in Oncological PatientsEnea Gino Di Domenico, Ilaria Cavallo, Francesca Sivori, et al.
Blood|June 2, 2007
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Elise Olsen, Eric Vonderheid, Nicola Pimpinelli, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Computational and Structural Biotechnology Journal|March 8, 2021
The Conundrum of Giglio Island: Unraveling the dynamics of an apparent resistance to COVID-19 - A descriptive studyAntonio Bognanni, Armando Schiaffino, Fulvia Pimpinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2006
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous LymphomasPier Luigi Zinzani, Pietro Quaglino, Nicola Pimpinelli, et al.
Dermatology Practical & Conceptual|November 14, 2025
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective StudyAntonella Di Cesare, Elia Rosi, Emanuele Trovato, et al.
Pageof 55

Showing results (481-490 of 542) with videos related to

Sort By:
Pageof 55
Italian Journal of Dermatology and Venereology|July 5, 2022
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologicsFrancesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|June 19, 2014
Follow-up of cutaneous melanoma patients: a proposal for standardizationE Moscarella, C Ricci, L Borgognoni, et al.
Cells|February 15, 2022
Characterization of <i>Gfat1</i> (<i>zeppelin</i>) and <i>Gfat2</i>, Essential Paralogous Genes Which Encode the Enzymes That Catalyze the Rate-Limiting Step in the Hexosamine Biosynthetic Pathway in <i>Drosophila melanogaster</i>Shawn Cotsworth, Catherine J Jackson, Graham Hallson, et al.
Dermatology Practical & Conceptual|December 4, 2023
Burden of Disease in the Real-Life Setting of Patients with Atopic Dermatitis: Italian Data From the MEASURE-AD StudyGiuseppe Argenziano, Santo Raffaele Mercuri, Paola Savoia, et al.
Frontiers in Cellular and Infection Microbiology|December 28, 2020
Biofilm Production by Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Significantly Increases the Risk of Death in Oncological PatientsEnea Gino Di Domenico, Ilaria Cavallo, Francesca Sivori, et al.
Blood|June 2, 2007
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Elise Olsen, Eric Vonderheid, Nicola Pimpinelli, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Computational and Structural Biotechnology Journal|March 8, 2021
The Conundrum of Giglio Island: Unraveling the dynamics of an apparent resistance to COVID-19 - A descriptive studyAntonio Bognanni, Armando Schiaffino, Fulvia Pimpinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2006
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous LymphomasPier Luigi Zinzani, Pietro Quaglino, Nicola Pimpinelli, et al.
Dermatology Practical & Conceptual|November 14, 2025
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective StudyAntonella Di Cesare, Elia Rosi, Emanuele Trovato, et al.
Pageof 55